ArticleViruses2021

Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2.

Aleksandr Ianevski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.